About GeneTex, Inc.

As a multinational antibody manufacturer, GeneTex’s primary goal is to provide researchers with thoroughly validated reagents to accelerate their discovery. Established in 1997 in San Antonio, Texas by scientists with expertise in clinical oncology, cancer biology, and infectious disease, the company’s initial focus was breast cancer biology and prognostic marker research. This evolved to incorporate a comprehensive portfolio of immunological reagents used for studying the entire spectrum of biomedical research. GeneTex is committed to the highest standards of product performance and is proud to offer antibody reagents supported by extensive research, development, and validation.